Abstract
Myeloproliferative disorders (MPDs) are defined as clonal stem cell diseases. the cardiovascular system is involved in 4 to 21% of MPD cases, presenting as acute ischemic coronary artery disease, valvular heart involvement, pericardial involvement, aortitis, thrombosis of major vessels, pulmonary embolism, systemic and pulmonary hypertension. Acute coronary syndrome may be the first manifestation of myeloproliferation.
Highlights
Myeloproliferative disorders (MPDs) are defined as clonal stem cell diseases
Acute coronary syndrome may be the first manifestation of myeloproliferation
MPDs are neoplastic disorders characterized by proliferation of the myeloid stem cell
Summary
Myeloproliferative disorders (MPDs) are defined as clonal stem cell diseases. The cardiovascular system is involved in 4 to 21% of MPD cases, presenting as acute ischemic coronary artery disease, valvular heart involvement, pericardial involvement, aortitis, thrombosis of major vessels, pulmonary embolism, systemic and pulmonary hypertension. Acute coronary syndrome may be the first manifestation of myeloproliferation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have